U01 HL083-1341/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	4
2007	2
2008	7
2009	1
2011	1
2024	0

1

Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.

Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS. Mega JL, et al. J Am Coll Cardiol. 2008 Jun 24;51(25):2422-9. doi: 10.1016/j.jacc.2008.01.069. J Am Coll Cardiol. 2008. PMID: 18565400 Free article.

2

Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.

O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, Sabatine MS. O'Donoghue M, et al. Circulation. 2006 Aug 8;114(6):550-7. doi: 10.1161/CIRCULATIONAHA.106.641936. Epub 2006 Jul 31. Circulation. 2006. PMID: 16880323 Clinical Trial.

3

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22).

Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S, Rifai N, Cannon CP, Morrow DA; TIMI Study Group. Wilson SR, et al. Am Heart J. 2011 Jun;161(6):1147-55.e1. doi: 10.1016/j.ahj.2011.02.014. Epub 2011 May 11. Am Heart J. 2011. PMID: 21641362 Clinical Trial.

4

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J; PEACE Investigators. Sabatine MS, et al. Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9. doi: 10.1161/ATVBAHA.107.151670. Epub 2007 Aug 31. Arterioscler Thromb Vasc Biol. 2007. PMID: 17766330

5

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.

Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, Rifai N, Cannon CP, Gerszten RE, Lee RT. Sabatine MS, et al. Circulation. 2008 Apr 15;117(15):1936-44. doi: 10.1161/CIRCULATIONAHA.107.728022. Epub 2008 Mar 31. Circulation. 2008. PMID: 18378613 Free PMC article.

6

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.

O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Wallentin L, Windhausen F, Sabatine MS. O'Donoghue M, et al. JAMA. 2008 Jul 2;300(1):71-80. doi: 10.1001/jama.300.1.71. JAMA. 2008. PMID: 18594042

7

Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy.

O'Donoghue M, Morrow DA, Cannon CP, Guo W, Murphy SA, Gibson CM, Sabatine MS. O'Donoghue M, et al. Eur Heart J. 2008 Apr;29(8):984-91. doi: 10.1093/eurheartj/ehn112. Epub 2008 Mar 16. Eur Heart J. 2008. PMID: 18346960 Clinical Trial.

8

Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).

Ray KK, Morrow DA, Shui A, Rifai N, Cannon CP. Ray KK, et al. Am J Cardiol. 2006 Oct 1;98(7):861-5. doi: 10.1016/j.amjcard.2006.04.024. Epub 2006 Aug 4. Am J Cardiol. 2006. PMID: 16996863

9

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL. Morrow DA, et al. Eur Heart J. 2008 May;29(9):1096-102. doi: 10.1093/eurheartj/ehn071. Epub 2008 Mar 12. Eur Heart J. 2008. PMID: 18339606 Free PMC article. Clinical Trial.

10

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.

Morrow DA, de Lemos JA, Sabatine MS, Wiviott SD, Blazing MA, Shui A, Rifai N, Califf RM, Braunwald E. Morrow DA, et al. Circulation. 2006 Jul 25;114(4):281-8. doi: 10.1161/CIRCULATIONAHA.106.628909. Epub 2006 Jul 17. Circulation. 2006. PMID: 16847150 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year